Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Juan-Francisco Grau"'
Autor:
Etienne Rouleau, Ana Oaknin, Christophe Klein, Alexandra Leary, Sebastien Gouy, Patricia Pautier, Catherine Genestie, Amandine Maulard, Judith Michels, Marco de Bruyn, Emeline Colomba-Blameble, Annechien Plat, Juan Francisco Grau Bejar, Elisa Yaniz Galende, Qinghe Zeng, Audrey Le Formal, Elodie Edmond, Maëva Moreau
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 7 (2024)
Background Patients with mismatch repair-deficient (MMRd) endometrial cancer (EC) can derive great benefit from immune checkpoint inhibitors (ICI). However not all responses and predictors of primary resistance are lacking.Methods We compared the imm
Externí odkaz:
https://doaj.org/article/07f2752f80f74236aa5694863f592740
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Juan Francisco Grau-Bejar, Carmen Garcia-Duran, David Garcia-Illescas, Oriol Mirallas, Ana Oaknin
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Cervical cancer still represents a major public health problem, being the fourth most common cancer in incidence and mortality in women worldwide. These figures are unacceptable since cervical cancer, an human papillomavirus-related malignancy, is a
Externí odkaz:
https://doaj.org/article/bc3db1ef64a243c6a5925718545b2c2c
Autor:
Juan-Francisco Grau, Lorena Farinas-Madrid, Carmen Garcia-Duran, David Garcia-Illescas, Ana Oaknin
Publikováno v:
International Journal of Gynecologic Cancer. 33:403-413
Cervical cancer represents a major public health problem, being the fourth most common cancer in incidence and mortality in women worldwide. Patients with recurrent, persistent, or metastatic disease unsuitable for curative therapeutic approaches hav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05f5c4af501d9642932e578ddb970fca
https://doi.org/10.1136/ijgc-2022-003758
https://doi.org/10.1136/ijgc-2022-003758
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
David Illescas, Carmen García-Durán, Víctor Navarro, Augusto Valdivia, Lorena Fariñas Madrid, Guillermo Villacampa, Ana Oaknin, Juan Francisco Grau, null Vall d’Hebron University Hospital, Barcelona, Spain
Publikováno v:
Gynecologic Oncology. 166:S240
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f74b1074068ecce430dbfa6ab5eaded
https://doi.org/10.1016/s0090-8258(22)01706-1
https://doi.org/10.1016/s0090-8258(22)01706-1
Autor:
Paula Romero Lozano, Maria Vila-Casadesús, Judit Matito, Carmen García-Duran, Deborah Grazia Lo Giacco, Marina Gómez-Rey, Juan Francisco Grau, Lorena Fariñas-Madrid, Eva Hernández-Illán, Agatha Martin, Cecília García, Ester Castillo, Josep Maria Miquel Aymar, Josep Tabernero, Ana Oaknin, Ana Vivancos
Publikováno v:
Journal of Clinical Oncology. 40:5547-5547
5547 Background: Copy number alterations (CNA) arise as a result of somatic changes to chromosome structure, resulting in gain or loss of genomic regions. A likely source of copy number variation is an incorrect repair of DNA damage that causes chrom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b56970369eca495faf69d686bc8e5b3
https://doi.org/10.1200/jco.2022.40.16_suppl.5547
https://doi.org/10.1200/jco.2022.40.16_suppl.5547
Publikováno v:
Journal of Cancer Metastasis and Treatment. 8:35
Cervical cancer is the fourth most common cancer in women worldwide, with a global incidence of 604,127 and an annual death rate of 341,831 in 2020. Patients with recurrent, persistent, or metastatic disease not amenable to curative therapy represent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd201aa60bc308baa63c6f5b96cbc12c
https://doi.org/10.20517/2394-4722.2022.34
https://doi.org/10.20517/2394-4722.2022.34
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 30(1)
BackgroundPatients with metastatic, recurrent, or persistent cervical cancer not amenable to local control and/or distant metastases have a very poor prognosis, only being candidates for palliative-systemic therapy. First line standard treatment in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c600abfb438aab6c6adb37f4c1eab284
https://pubmed.ncbi.nlm.nih.gov/31645423
https://pubmed.ncbi.nlm.nih.gov/31645423